On the shopping list: Isis Pharmaceuticals
Notes: Stock Ratings: 1 = buy at current stock prices, 2 = buy on a 5-10% dip in stock price, 3 = sell on a 5-10% increase in stock price, 4 = sell at current stock prices to raise cash. Ratings are based upon 12-18 month outlook on stock direction and not necessarily related to moves I make due to financial positioning. As I stated when the sale of NPS Pharma was closed, I have been looking for a new speculative stock to get myself into.The stock that most interests me at this time is Isis Pharmaceuticals. Isis is a small biotech company (market cap of ) whose focus is discover and develop antisense drugs with a primary focus on rare and severe conditions. That's a bit of a mouthful so, to clarify, antisense therapies are those that take advantage of the human genome sequencing that has been done. It takes certain genetic sequences that are known to cause conditions or be related to problematic cellular activities, and then uses that knowledge to create...